4.5 Article

Cytosolic O-glycosylation is abundant in nerve terminals

Journal

JOURNAL OF NEUROCHEMISTRY
Volume 79, Issue 5, Pages 1080-1089

Publisher

WILEY-BLACKWELL
DOI: 10.1046/j.1471-4159.2001.00655.x

Keywords

beta-synuclein; collapsin response mediator protein-2; (CRMP-2/DRP/TOAD-64/Ulip); gracile axonal dystrophy; neurophosphoprotein 14; Parkinson's disease; ubiquitin carboxyl hydrolase-L1

Funding

  1. NICHD NIH HHS [HD13563] Funding Source: Medline
  2. NINDS NIH HHS [NS09415] Funding Source: Medline

Ask authors/readers for more resources

Phosphorylation plays a key role in regulating growth cone migration and protein trafficking in nerve terminals. Here we show that nerve terminal proteins contain another abundant post-translational modification: beta -N-acetylglucosamine linked to hydroxyls of serines or threonines (O-GlcNAc(1)). O-GlcNAc modifications are essential for embryogenesis and mounting evidence suggests that O-GlcNAc is a regulatory modification that affects many phosphorylated proteins. We show that the activity and expression of O-GlcNAc transferase (OGT) and N-acetyl-beta -D-glucosaminidase (O-GlcNAcase), the two enzymes regulating O-GlcNAc modifications, are present in nerve terminal structures (synaptosomes) and are particularily abundant in the cytosol of synaptosomes. Numerous synaptosome proteins are highly modified with O-GlcNAc. Although most of these proteins are present in low abundance, we identified by proteomic analysis three neuron-specific O-GlcNAc modified proteins: collapsin response mediator protein-2 (CRMP-2), ubiquitin carboxyl hydrolase-L1 (UCH-L1) and beta -synuclein. CRMP-2, which is involved in growth cone collapse, is a major O-GlcNAc modified protein in synaptosomes. All three proteins are implicated in regulatory cascades that mediate intracellular signaling or neurodegenerative diseases. We propose that O-GlcNAc modifications in the nerve terminal help regulate the functions of these and other synaptosome proteins, and that O-GlcNAc may play a role in neurodegenerative disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available